Dr Razan R Al Kudsi, MD | |
16259 Sylvester Rd Sw, Suite 401, Burien, WA 98166-3049 | |
(206) 242-8837 | |
(206) 431-5549 |
Full Name | Dr Razan R Al Kudsi |
---|---|
Gender | Female |
Speciality | Nephrology |
Experience | 50 Years |
Location | 16259 Sylvester Rd Sw, Burien, Washington |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1497790687 | NPI | - | NPPES |
1073238 | Medicaid | WA | |
110061080 | Other | WA | RR MEDICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RN0300X | Internal Medicine - Nephrology | MD00028577 (Washington) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Nkc Seattle Kidney Center | Seattle, WA | Dialysis facility |
Entity Name | Razan R Al-kudsi Md |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1831110782 PECOS PAC ID: 8224131735 Enrollment ID: O20070321000068 |
News Archive
Asthma afflicts more than 300 million people worldwide. The most severe manifestation, known as non-Th2, or non-atopic childhood asthma, represents the majority of the cases, greater than 85%, particularly in low-income countries, according to Hyunok Choi, an associate professor at the Lehigh University College of Health.
In an analysis from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, one of the largest studies of its kind to determine whether intensive blood glucose (sugar) control worked better than standard blood sugar control among diabetics, results show that the benefits of intensive therapy need to be balanced against the increase in total and cardiovascular disease-related death, increased weight gain, and high risk for severe low blood sugar.
The Enterprise Center at Salem State College today announced that three companies have been named as finalists in the North of Boston Business Plan competition. The finalists include companies that provide online local advertising, environmentally responsible household products and a solar energy business.
The drug aclidinium bromide has been approved since October 2012 for widening the narrowed airways of adults with chronic-obstructive pulmonary disease (COPD). The German Institute for Quality and Efficiency in Health Care (IQWiG) has now examined the added benefit of the drug pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG).
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Razan R Al Kudsi, MD 16259 Sylvester Rd Sw, Suite 401, Burien, WA 98166-3049 Ph: (206) 242-8837 | Dr Razan R Al Kudsi, MD 16259 Sylvester Rd Sw, Suite 401, Burien, WA 98166-3049 Ph: (206) 242-8837 |
News Archive
Asthma afflicts more than 300 million people worldwide. The most severe manifestation, known as non-Th2, or non-atopic childhood asthma, represents the majority of the cases, greater than 85%, particularly in low-income countries, according to Hyunok Choi, an associate professor at the Lehigh University College of Health.
In an analysis from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, one of the largest studies of its kind to determine whether intensive blood glucose (sugar) control worked better than standard blood sugar control among diabetics, results show that the benefits of intensive therapy need to be balanced against the increase in total and cardiovascular disease-related death, increased weight gain, and high risk for severe low blood sugar.
The Enterprise Center at Salem State College today announced that three companies have been named as finalists in the North of Boston Business Plan competition. The finalists include companies that provide online local advertising, environmentally responsible household products and a solar energy business.
The drug aclidinium bromide has been approved since October 2012 for widening the narrowed airways of adults with chronic-obstructive pulmonary disease (COPD). The German Institute for Quality and Efficiency in Health Care (IQWiG) has now examined the added benefit of the drug pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG).
› Verified 7 days ago
Sherry Parker, RN Nephrology Medicare: Not Enrolled in Medicare Practice Location: 117 Sw 160th St, Burien, WA 98166 Phone: 206-242-2030 | |
Scott Slaymaker, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 16110 8th Ave Sw, Ste A-2, Burien, WA 98166 Phone: 206-242-8280 Fax: 206-242-8302 | |
Jeanne M Isaacson, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 16259 Sylvester Rd Sw, Suite 504, Burien, WA 98166 Phone: 206-242-7900 | |
Bonnie J Takasugi, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 16233 Sylvester Rd Sw, Suite 110, Burien, WA 98166 Phone: 206-241-2622 Fax: 206-241-4429 | |
Cameron Gordon Hampton Smith, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 16045 1st Ave S Fl 1, Burien, WA 98148 Phone: 206-965-4100 Fax: 206-965-4119 | |
Dr. Richard Lawrence Olstein, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 16233 Sylvester Rd Sw Ste 260, Burien, WA 98166 Phone: 206-835-7400 Fax: 206-835-7439 | |
Dr. Christopher W. Duncan, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 16233 Sylvester Rd Sw, G-20, Burien, WA 98166 Phone: 206-431-9771 Fax: 206-431-5484 |